Drug Abuse Archives - Page 4 of 13 -

Opioids on Wall Street: Addictions Influence on White-Collar World

Opioids on Wall Street: Addictions Influence on White-Collar World

(This content is being used for illustrative purposes only; any person depicted in the content is a model)

The opioid crisis has affected every community in America. Opioids affect rural working class people, those in the inner city and suburbs, or even the wealthy and well-to-do professionals. While drug abuse in business has been highlighted in blockbuster films like the Wolf of Wall Street, the current reality is not far from it. According to addiction experts, substance use disorder is making a sobering impact on the financial industry.

This comes from not just an upscale partying lifestyle, but also from drugs used to manage performance and stress, along with physical pain. According to addiction experts, the financial industry itself is actively turning a blind eye to the issues concerning opioid abuse on Wall Street because money is still the priority, and stigma still gets in the way.

Opioids on Wall Street: White-Collar Confessions

As it stands there is no comprehensive research that takes a detailed look at opioid abuse in Wall Street among finance professionals. So we can’t exactly show the numbers to prove it’s prevalence. However, what we see consistently is a dramatic increase in addiction and overdose rates all over the nation in recent years.

Luckily, professionals from this demographic are beginning to speak out in hopes of progressive change.

One such individual is Trey Laird, a former Wall Street trader, who recently spoke to CNBC about his six-year opioid addiction. During the conversation Laird reiterates the critical understanding that substance use disorder can reach anyone, saying:

“Addiction pervades every single socioeconomic demographic that there is. Every industry, every race, men, women. It doesn’t care who you are,”

After getting clean himself, Laird went on to open a sober living community and says he hopes to specifically serve the Wall Street and white collar demographic.

According to Laird, there has been more talk about opioid addiction among people in higher socioeconomic brackets, but there is still much work that needs to be done. He acknowledges that increasing awareness is doing a great deal, but that the problem is also at an increase. Wall Street may finally be talking about it, but how many professionals will get the help they truly need?

Opioids on Wall Street: Stocks and Stigma

One of the biggest obstacles facing white-collar workers like those in Wall Street is the engrained stigma still attached to addiction. Even with all the shifts in our culture toward a better understanding of substance use and the compassion for those struggling, professionals still have this seemingly unbearable hurdle in front of them.

Truthfully, stigma is something that prevents most people from getting help. Professionals will often be too afraid of losing their jobs to admit they need help. Many in the world of Wall Street and finance may have no information on how to seek out treatment while adhering to their professional boards’ guidelines and business practices.

With white-collar workers, this may be an especially difficult thing because the idea of addiction is so often attached to stereotypes of the unemployable, the homeless, the unreliable and unstable that their high-earning careers might minimize the impact drugs have on their lives. Wall Street stockbrokers and traders might not see themselves as having a problem as long as they can function, which brings in the idea of the “functioning addict.”

Opioids on Wall Street: Function Addiction is Still Addiction

Many white-collar workers who struggle with drugs or alcohol may consider themselves a “functioning addict”, meaning they are less likely see their actions as a problem because they are able to maintain their professional or even personal lives. To make matters worse, frequently the people around someone who is professionally successful will not believe the addiction is real. They may admit that you’ve been careless or destructive in some respects, but will ultimately minimize it due to your financial stability.

As long as you’re making money and paying the bills how could you possibly be “that bad?”

Well, because “functioning addiction” is still an addiction.

Addiction isn’t about whether or not you are able to hold down a steady income. It does not depend on whether or not other people recognize that you have a problem or your competence with your profession. While addiction can and will have an impact on these things, it isn’t always as black and white as most people like to pretend.

Notice how earlier we said you may “maintain” other areas of your life? Well, we mean to say that you can get by for a while, but eventually, the effects of addiction will catch up with you. It could be in the form of serious health consequences or other devastating circumstances. It could take days, months or even years, but it will leave a mark.

Sadly, “functioning addicts” are also far less likely to get the help they desperately need.

Opioids on Wall Street: It Could Be You

While you might be able to keep your addiction secret, in the beginning, things will eventually get worse. Eventually, your addiction will become unmanageable.

If you think you might fit the “functioning addiction” criteria, look at the following questions and answer them honestly.

  • Do you often think about using drugs or drinking?
  • Do you find it hard to stop after you start drinking or using?
  • Are you scheduling your time around drinking or using drugs?
  • Have you tried to stop before, but found that you were unable to?
  • Do you drink or use drugs first thing in the morning?
  • Are you drinking or using drugs at work?
  • Do you hide your drug use or drinking?
  • Have you done something risky, like driven drunk?
  • Do you worry about your drug use or drinking?

If you find you are answering “yes” more than “no” then you should seriously consider speaking with a medical or addiction professional about your drug use or drinking.

The opioid crisis is nothing to be ignored. Despite all that we think we have learned about addiction too many professionals don’t get the help they need. No one is exempt from the destruction of addiction. Opioids don’t care what street you work on, Wall Street or not, they can ruin your life all the same. If you or someone you love is struggling, please call toll-free now. We want to help.

 CALL NOW 1-888-922-5398

Jeff Sessions Reversing Obama-Era Policy on Legal Marijuana

Jeff Sessions Reversing Obama-Era Policy on Legal Marijuana

Before the hype around recreational use of marijuana in California could even begin to dwindle, new reports are stating that President Trump’s Attorney General Jeff Sessions is planning to begin a federal crackdown on marijuana laws.

Jeff Sessions is set to announce today that he is rescinding memos sent out from the Obama administration that established a policy of non-interference with state laws concerning marijuana use. For some time now there have been several stories highlighting Jeff Sessions’ disagreement with allowing states to decide their own laws concerning medical or recreational marijuana use. Some sources indicate he has been planning a new strategy that will actually bring federal law to a head against state marijuana policies.

UPDATE: According to The Washington Post, Jeff Sessions notes in a memo sent to U.S. attorneys that federal law prohibits the possession and sale of marijuana. Sessions undid four previous Obama administration memos that advised against bringing prosecutions in states where marijuana was legalized to use for recreational or medical purposes. Sessions said prosecutors should use their own discretion in weighing whether charges were appropriate.

So what does all this mean for marijuana states?

The Obama Era Policy

The memo essentially describing the Obama-era policy through the Justice Department is known as the “Cole Memo”. It was named after then-Deputy Attorney General Jim Cole in 2013.

The “Cole Memo” outlined new priorities for federal prosecutors in states legalized use of marijuana. These shifts in policy represented a major change from the strict enforcement approach of past administrations to an attitude of non-interference. Back in 2014 U.S. Congress approved legislation preventing the DEA from carrying out any raids, arrest, or prosecutions of patients using medical marijuana. Congress also blocked law enforcement agencies under the Justice Department from consuming federal dollars in efforts to enforce federal marijuana laws in states that have legalized the use of medicinal marijuana. Under President Barack Obama, the Department of Justice did not pursue action against states that legalized recreational marijuana use. In 2015 there was a bipartisan effort in Congress to block the DEA from using federal funding for aggressively pursuing marijuana in the states where it was legalized.

The Obama era outline essentially allowed states to decide whether or not to legalize marijuana and to what extent. The federal prosecutors would not intervene as long as the state regulations did not threaten other federal priorities. So the distribution of marijuana to minors and cartels was still prohibited.

So with this announcement, many are wondering if Jeff Sessions will be working to undo other changes as well.

The Jeff Sessions Reversal

At the time of writing this article, whether or not Jeff Sessions will offer up a new strategy for dealing with marijuana-friendly states or not has yet to be seen. At this time the great concern is how this announcement may end up putting state and federal law in conflict, and what to expect out of enforcement from the federal government.

But many say this is a frustrating development, especially considering that President Trump has said in the past that he would not allow his attorney general to change the current policy, telling a reporter that,

“I’m a states person. I think it should be up to the states, absolutely.”

If we go back to February of 2017, Sean Spicer suggested in a press conference that the Trump administration and the Justice Department already had the intentions to no longer turn a blind eye to states with their own legal marijuana laws. At the time Spicer said the Trump administration would be “taking action” against these states. Contradicting all the talk of states’ rights and rolling back federal enforcement.

Many are wondering if President Trump was consulted about this decision, or if he has been made aware of the implications of this change. Especially since it goes against his original campaign promise to leave marijuana laws to the states.

This move would lay the groundwork for the federal government to begin a crackdown on the rapidly increasing marijuana industry all across the country. If these reports are confirmed this afternoon with no new innovations in their place, this move could have a drastic impact on the economics around the marijuana industry.

Sessions Track Record

However, this should all come as no surprise, since Jeff Sessions has repeatedly spoken out against decriminalization of marijuana and a return to the failed tactics of the War on Drugs at every turn.

In fact, a key adviser on marijuana policy to Jeff Sessions, Dr. Robert DuPont, believes drug testing should be a routine part of primary-care medicine. He has gone as far to suggest that primary-care physicians should be given the power to force some patients into treatment against their will. DuPont also suggests the following treatment to subject individuals to monitoring and random drug tests for up to 5 years.

Dr. Robert DuPont was among a small group of drug-policy experts involved last month in a closed-door meeting with Sessions to discuss federal options for dealing with the rapid liberalization of state marijuana laws.

The Marijuana States

Eight states and the District of Columbia have laws allowing for personal consumption of marijuana for recreational purposes. 28 states and the District of Columbia have legalized marijuana for medical use. Even more states recently have begun to talk about changes in their own policies. California voters pushed through legislation to legalize recreational use back in November of 2017, and with the start of the New Year, those laws went into effect. Now, not even a week later, the fate of this state’s new policy is hanging in the balance.

Needless to say, marijuana advocates all over the nation are troubled by this news. According to NORML Political Director Justin Strekal,

“If the Trump administration goes through with a crackdown on states that have legalized marijuana, they will be taking billions of dollars away from regulated, state-sanctioned businesses and putting that money back into the hands of drug cartels,”

But some states are not ready to give up on their marijuana laws. Other Republicans, such as Colorado Senator Cory Gardner, are avidly speaking out in opposition to the recent decision by Jeff Sessions. Senator Gardner has vowed to prevent any new appointees for the Department of Justice from being confirmed until this reversal has been reversed.

Hopefully, when Jeff Sessions makes his official announcement, we will have some more clarity on how the federal government plans to address marijuana use going forward.

Marijuana Abuse

While the legal status of marijuana may soon be up for a serious debate, the fact remains that it is still possible to abuse marijuana. Whether a drug is legal or not, there are still risks. There are already plenty of legal drugs that cost thousands of lives every year. When substance use becomes habitual it can be extremely harmful to an individual who struggles with substance use disorder. Even though marijuana is not claiming lives like the opioid epidemic, for some it has adverse effects on the quality of life.

While marijuana is not considered to be as dangerous as other illicit drugs, such as heroin or methamphetamines, it can cause dependence for people who use the drug. The typical consensus that marijuana is not as physically destructive and addictive as other “harder” drugs doesn’t change the fact that psychiatrists also believe the psychological impacts of a substance do matter when talking about an addiction. These effects can be just as detrimental.

Marijuana addiction treatment offers a safe and secure environment while providing a variety of therapeutic opportunities to help develop a healthy lifestyle without relying on the use of marijuana or other drugs.

There still needs to be resources available to help people who suffer from abuse. Supporting addiction recovery means breaking the stigma and offering holistic and effective solutions. Palm Healthcare Company is here to help. If you or someone you love is struggling, please call toll-free now.

 CALL NOW 1-888-922-5398

Palm Healthcare Company Blog: Top 9 Stories from 2017

Palm Healthcare Company Blog: Top 9 Stories from 2017

With the beginning of the new year, Palm Healthcare Company is looking forward to helping spread more exciting stories of experience, strength, and hope while also sharing important news stories and exciting new developments that relate to the world of addiction recovery and substance use disorder treatment. As we commit ourselves to another year of fighting alongside thousands of people working toward a better future, we would also like to take some time looking back on all the big moments in 2017 that we shared with our Palm Healthcare Company Blog.

  1. President Trump Declares Public Health Emergency: What’s the Plan?

President Trump Declares Public Health Emergency: What’s the Plan?

October of 2017, President Donald Trump made an announcement declaring the opioid crisis in America as a Public Health Emergency. This highly anticipated declaration was delivered in a way slightly different than many had expected, noting the technical differences between a Public Health Emergency and a National Emergency.

Many advocates were concerned that this announcement did not provide a concrete foundation for the necessary federal funding and did not initiate much-needed action, but others we assured that this means the Trump administration was taking this issue very seriously. In this article, we took a look at what this announcement did actually accomplish, and what it failed to deliver on.

  1. Racketeering for Fentanyl: Opioid Maker Insys Founder Arrested for Bribes

Racketeering for Fentanyl: Opioid Maker Insys Founder Arrested for Bribes

A huge development to another story came in late 2017 when John Kapoor, former CEO of Insys Therapeutics and founding father of one of the most prominent opioid manufacturers in the country, was arrested and charged with conspiring to push the signature drug of Insys Therapeutics, a Fentanyl spray called Subsys, for unacceptable uses through bribes and kickbacks.

The Palm Healthcare Company blog notes how back in 2016 the Justice Department reported to be charging 6 former executives and sales-managers of Insys Therapeutics for conspiring to defraud health insurers.

When looking at the details in this story, it has intensified the conversation about Big Pharma involvement in the epidemic

  1. Can Kellyanne Conway Really Compete with the Opioid Crisis?

Can Kellyanne Conway Really Compete with the Opioid Crisis?

Not too long after President Trump’s declaration of a Public Health Emergency pertaining to the opioid crisis, Kellyanne Conway was announced as leading the charge on the White House’s efforts for addressing the opioid epidemic.

This Palm Healthcare Company blog saw a lot of comments!

While some find that having a high-profile figure at the head of the efforts gives validity to the White House’s commitment to solving the opioid issue in America, many others are speaking out in frustration. Those in opposition to this appointment say that while she may be useful as a counselor or pollster, she has no experience of expertise when it comes to drug abuse, addiction or substance use disorder treatment.

Thus far the one thing both Kellyanne and the President seem adamant about is a media campaign, but advocates are still afraid this is more “Just Say No” and not enough support for effective resources.

  1. After Las Vegas Shooting: PTSD and Mental Health Must be Priority

After Las Vegas Shooting: PTSD and Mental Health Must be Priority

In early October of 2016, the nation was shaken to its core when Las Vegas had one of the deadliest shootings in modern American history. This horrific tragedy flooded newsrooms and live viral footage with the country watching in shock as a gunman killed 58 people and injured 546 more at an outdoor music festival.

In the aftermath of this terrible and heartbreaking incident, our Palm Healthcare Company blog took a look at how such traumatic experiences impact people, and about the importance of those who struggle with Post-traumatic Stress Disorder (PTSD) getting proper diagnosis and care.

At a time when so many people are self-medicating with dangerous or even deadly narcotics, it is important to care for those most vulnerable, especially after such an earth-shattering experience.

  1. Police Helping Addicts into Treatment is a Growing Trend Saving Lives 

Police Helping Addicts into Treatment is a Growing Trend Saving Lives

In August of 2017, we took a look back at several programs that had come to light all over the country based on Police Departments working with their communities to offer drug users the chance to get help with addiction treatment instead of being arrested and charged.

The pioneering program came from Gloucester Police Department in Massachusetts back in 2015. This program allowed users to ask police for help, and told addicts they could submit drugs to local law enforcement without fear of being arrested if they were willing to seek treatment. A 2016 study showed that this program was experiencing some impressive success.

Police departments in a number of other states were inspired by this and took up similar programs as a way to help their communities fight the addiction outbreak.

The Palm Healthcare Company blog took a close look at a handful of these programs to celebrate their compassion and success.

  1. Sterilized for Cash: This Woman Pays Drug Addicts to Not Have Kids 

Pregnant lady’s stomach and her hand holding dollar over black background

When we posted this Palm Healthcare Company blog we saw a great deal of debate in the comments on our Facebook. For over 20 years, Barbara Harris has driven across the country using cash to ask addicted women to give up their fertility. To date, the organization has paid over 7,000 people.

The controversy around such a powerful story had some people showing a great deal of support for someone giving addicted women an incentive to not get pregnant, while other people were appalled and angered that someone would entice desperate women who are not in the right mindset to make such dramatic and life-altering decisions with their bodies.

  1. What Chester Bennington Taught Us about Addiction and Depression

What Chester Bennington Taught Us about Addiction and Depression

(This content is being used for illustrative purposes only; any person depicted in the content is a model)

In July of 2017, the world lost a great artist and inspirational musician with the death of Chester Bennington, the lead singer of the band Linkin Park.

Initial reports were that Bennington had died from suicide by hanging, with later reports indicating that Chester had been drinking at the time of his death. The vocalist had been open about his struggles with depression and drug addiction over the years, and in this article, we took a look at just how much Chester Bennington could teach us about the devastation of depression and addiction.

  1. Dear Media, Thank You for Bad Press 

Dear Media, Thank You for Bad Press: Love, South Florida

South Florida has been under a great deal of scrutiny recently, specifically concerning the issues facing the recovery community such as unethical and illegitimate sober home operators in the area. In June, there was a Megyn Kelly NBC News Investigation which focused in on Delray Beach, Florida and some of the big problems concerning unscrupulous activities from corrupt individuals exploiting drug addicts in need of help.

We took this time to look over some of the bigger stories concerning the illicit activities in South Florida with the recovery industry while showing support and gratitude for all those working together to try and put an end to operators who are taking advantage of people in need of help.

  1. Palm Healthcare Measures Up to Addiction Treatment Outline for EAP

Palm Healthcare Measures Up to Addiction Treatment Outline for EAPs

In September of 2017, we took a very close look at an article written by the Journal of Employee Assistance that was designed to help Employee Assistance Programs (EAPs) find the right kind of addiction treatment programs to recommend to their clients.

The outline given for EAPs to find effective and reliable addiction treatment options gives a list of things to look for. The Palm Healthcare Company blog was happy to show off just how all of our facilities measure up to these crucial standards.

Keep an Eye Out for More

Palm Healthcare Company continues to try and share every treatment development, news story or exciting innovation on our blog to not only help more people learn and raise awareness but to offer some perspective and maybe ask some new questions.

Whether it is sports, celebrities, news or politics we are committed to talking about important stories that pertain to drug policy in America, substance use disorder, mental health, and personal wellness. We will continue to touch on the top stories of 2018 to spread the word and hopefully inspire more people to get involved in these crucial conversations.

2017 was an intense, innovative and inspiring year. Here is to hope for 2018.

Holistic addiction treatment means incorporating every aspect of life for each individual with personalized opportunities for lasting recovery. So every bit of information can help anyone make a more comprehensive decision about what kind of recovery plan they want. If you or someone you love is struggling, please call toll-free now.

 CALL NOW 1-888-922-5398

Fentanyl Busts in Ohio Seize Enough Drugs to Kill the Whole State

Fentanyl Busts in Ohio Seize Enough Drugs to Kill the Whole State

In 2014 the state of Ohio was #2 for most overdose deaths in all of America with approximately 2,744 deaths. For 2016 early estimates are putting that number at 4,149 Ohioans who lost their lives, a 36% climb from 2015, the year when the Buckeye State had by far the most overdose deaths in the nation.

On average, 11 people died every day from heroin, fentanyl, carfentanil and other drugs in Ohio through 2016.

As the nation grapples with these skyrocketing body counts from coast to coast, more government and law enforcement officials are trying to find new ways to take action against the opioid crisis. For those who do not know, fentanyl is a synthetic opioid; one of the most dangerous drugs on the illicit market.

But recently the Capital City of the Midwest has scored a huge win in that fight.

Enough to Kill Columbus

Back in October one drug bust led to investigators discovering 2 kilograms, or 4.5 pounds, of fentanyl in the trunk of a car. To put this in perspective, the Franklin County Prosecutor Ron O’Brien stated that:

  • A fatal dose of fentanyl is considered to be only 2-3 milligrams.
  • In Columbus, Ohio the population is approximately 860,000 people.

Crunching the numbers, the prosecutor points out this amount of the incredibly lethal synthetic drug could have killed every man, woman, and child in the city.

Three California men were arrested in relation to this bust.

Enough to Kill Ohio

Just when you think you’ve heard the worst of it, that’s not even the tip of the iceberg.  The following month police in the capital city seized 20 pounds of pure fentanyl. In regards to this case, Ron O’Brien said,

“So it would probably be enough to kill all, the entire population in the state of Ohio.”

Again, using the same lethal fentanyl dosage for perspective, Ohio has 11.6 million residents. The amount of fentanyl discovered in the November bust could potentially kill more than 9 million people. O’Brien included,

“Two or three milligrams of fentanyl is not much more than five or six small grains of salt.”

So it stands to reason that 20 pounds of this drug could easily wipe out the vast majority of the inhabitants of the state.

More Record Busts this Year

The opioid epidemic is the greatest drug crisis in the history of the country. As the problem has intensified, the spread of fentanyl and carfentanil has continued to bring dead and devastation. Luckily, there are more major opioid busts this year, with some seizing enough fentanyl to kill entire populations of several states.

New York

In August officials of the Empire State managed to seize more than 140 pounds of fentanyl in August. The Drug Enforcement Administration said that amount could’ve killed nearly 32 million people. Put more bluntly, this amount of fentanyl could wipe out the populations of Texas and Oklahoma… combined!

San Diego

Back in June officials in this major California city found close to 100 pounds of fentanyl. That is enough to kill 22.4 million people; that is the combined populations of:

  • New York
  • New Hampshire
  • Maine

St. Louis

The Gateway to the West was able to catch nearly 60 pounds of pure fentanyl back in April. That alone is enough to kill more than 13.6 million people.

Fighting the Spread of Fentanyl

Back in Ohio, Ron O’Brien and other officials know the opioid epidemic is getting worse all over the country. The Center for Disease Control and Prevention’s latest drug report states:

  • More than 33,000 people died from opioid-related drug overdoses in 2015
  • Close to 10,000 of them were from synthetic opioids such as fentanyl

In the state of Ohio, the opioid crisis has placed an increasing strain on resources. Financially it is costing Ohio residents between $6.6 and 8.8 billion per year, according to some experts. That is almost as much as the state spends on education for grades K-12.

Yet the fight goes on.

These massive seizures of this lethal synthetic chemical have undoubtedly saved many lives. However, putting a complete stop to the illicit drug trade is still very far off, if at all possible. Still, taking a few hundred pounds of such a potent and potentially deadly drugs off the streets makes an immeasurable difference.

For more important information on the dangers of prescription drugs, download our FREE E-BOOK “Big Secrets of Big Pharma: Why They Secretly Hope You Get Hooked”

DOWNLOAD FREE E-BOOK

Treating Opioid Abuse

Holistic drug addiction treatment is an effective and important resource for helping people struggling with substance use disorder, especially in the wake of the opioid crisis in America.

Outbreaks of more life-threatening drug problems including fentanyl and other hazardous synthetics only make the need for supportive and impactful treatment more relevant. If we want to overcome the opioid epidemic there must be an emphasis on how we treat people struggling and on how we support them through the recovery process.

Treating opioid abuse is about building a strong foundation with safe medical detox, personalized therapy, and innovative treatment opportunities. Palm Healthcare Company helps thousands of people all over the country overcome opioid abuse. Our facilities are committed to providing quality care for those dealing with drug abuse, whether it is illicit drugs or prescription drug dependence. If you or someone you love is struggling, please call toll-free now. We want to help.

 CALL NOW 1-888-922-5398

Can Kellyanne Conway Really Compete with the Opioid Crisis?

Can Kellyanne Conway Really Compete with the Opioid Crisis?

This past Wednesday, Attorney General Jeff Sessions made the announcement that White House counselor Kellyanne Conway will be the Trump administration’s go-to for opioid crisis efforts. This announcement has been met with both praise and criticism. Some say this appointment actually gives validity to the White House’s commitment to solving the ongoing opioid epidemic, while others see it as the exact opposite.

For a little background, Kellyanne Conway worked as a pollster before becoming Trump’s campaign manager during his run for the 2016 presidential nomination. Currently, Conway serves as a White House spokeswoman and Trump surrogate. She has been seen on countless panels discussing the biggest topics and politics. She absolutely has her work cut out for her, so can Kellyanne Conway compete?

The Kellyanne Cons and Pros

So can this infamous Trump advocate, the woman who practically accidentally coined the phrase “alternative facts” compete with the opioid crisis in America? Kallyanne Conway has become notorious for defending some of President Trump’s most flagrant and controversial “alternative facts” in the media. But in her defense, she also has said some things that seem to highlight important prospects for this problem.

So here are some things to consider when we talk about Kellyanne Conway being put in charge of the opioid epidemic.

Lack of Experience

One of the big problems with this appointment people are pointing out is the lack of experience. Critics say this appointment speaks to how little passion the current administration is actually putting into fighting the opioid crisis since Kellyanne Conway has no experience in public health or with drug policy.

But in a time where Americans seem to be putting more trust in people that don’t typically meet the description of “qualified” in hopes that an outsider might bring better results, it makes sense that a lot of people might still hope Kellyanne can do some good.

Yet, there are still those who aren’t so sure. Tom Synan, a police chief and member of the Hamilton County Heroin Coalition in Ohio tweeted in response to the announcement:

“Ummm… did we run out of Dr’s, cops, addiction specialists or people who are actually dealing with this on the street to lead this?”

As a first responder, Synan is one of many people who are frustrated with the current actions being taken.

“I don’t want to get involved in politics, but it seems like it is a political position … I think I would have gone out to the country and tapped into people who are national experts who are on the street who are literally dealing with this issue every day,”

It seems many on the front lines are not impressed with the Trump administration’s move to put Kellyanne Conway in charge of efforts to combat one of the worst drug problems in the nation’s history.

Publicity and Perception

During a press briefing about the Justice Department’s efforts to combat the crisis where the announcement was made, Sessions said President Donald Trump chose Kellyanne Conway to “change the perception” about opioids and reduce addictions and deaths.

According to Sessions, President Trump has made the epidemic “a top priority for his administration, including every senior official and Cabinet member.”

An opioid policy expert Andrew Kolodny of Brandeis University actually defended the move when speaking to BuzzFeed News, stating:

“It is a positive sign. She is a high-profile figure in the administration, showing the administration takes this seriously,”

Some believe this can offer a sign of hope for more concrete action since many recovery advocates say despite the declaration of a public health emergency from President Trump there has been very little action taken to change the state of the epidemic.

Bertha Madras, a member of the President’s Commission on Combating Drug Addiction and the Opioid Crisis and Harvard Medical School professor, said:

“The most important thing that Kellyanne Conway will provide is access … but also commitment… She was at all the meetings, she listened and took copious notes.”

Let’s hope those are some good notes because thus far the opioid problem in America has shown no signs of slowing down. Jeff Sessions justified the appointment by saying Kellyanne Conway “understanding messaging” and can help turn around public perception. But is this about publicity, or is it about the preservation of life?

Surely breaking the stigma and changing the way addiction is viewed does matter, but should someone who specializes in making things look good to be in charge of how this country deals with one of the most prominent crises we face?

Treatment and Resources

Kellyanne does seem to support treatment, but to what extent it is still unclear. In one interview with ABC Kellyanne Conway did say,

“Pouring money into the problem is not the only answer. We have to get serious about in-facility treatment and recovery.”

So she at least appears to understand how crucial effective inpatient treatment is for recovery.

But when reporters mentioned the fact that there needs to be funding for these programs, she put more emphasis on “a 4 letter word called will” that seems to side-step the question- where will these resources come from?

As it now stands, White House has:

  • Left the leadership role of the Office of National Drug Control Policy vacant
  • Failed to release any written opioid-control strategy
  • Not requested funds to replenish the national public health emergency fund that currently sits at just $66,000

In fact, President Trump’s 2018 budget request would increase addiction treatment funding by less than 2%. And don’t be fooled, that increase includes the $500 million already appropriated by Congress in 2016 under the 21st Century Cures Act with the Obama administration.

Even Chris Christie, the Republican New Jersey Governor who led the White House Opioid Commission, said:

“In New Jersey, we are spending $500 million,” he said. “I am not, quite frankly, impressed with $1 billion from the federal government for the nation.”

Strict Prevention and Punishment

When you look at what she has said on record in regards to opioids and addiction, it doesn’t really inspire a great deal of confidence. Kellyanne Conway has consistently hinted to an outdated ideology of what addiction is and how to address it.

In the past, Kellyanne has said,

“The best way to stop people dying from overdoses and drug abuse is by not starting in the first place… That’s a big core message for our youth.”

That’s right; just say no.

Critics say this aligns with the mindset of Jeff Sessions and others in the White House who seem to think that ‘Just Say No’ tactics actually work, or that purely prevention-based programs like D.A.R.E. can solve the whole problem. While prevention is important, it has proven to be ineffective as a focal point when addressing addiction.

Circling back to publicity, what Ms. Conway does seem to heavily endorse is a White House investigation for a “national ad campaign” on abuse prevention. President Trump himself had voiced his own support for a national advertising initiative to try and deter drug use.

But we all remember those commercials- this is your brain on drugs- and they didn’t really help that much.

Again, it seems Attorney General Sessions and the current administration is more focused on punishment than treatment and strict law enforcement. Sessions said the Justice Department was giving more than $12 million in grants to state and local law enforcement to help them prosecute crimes connected to:

Sessions is also ordering all U.S. Attorney offices to designate opioid coordinators. Kaitlyn Boecker, Policy Manager with the Drug Policy Alliance, has been vocal in her disapproval of the current steps being taken.

“Despite declaring the opioid overdose crisis a public health emergency just last month, the Trump Administration continues to emphasize failed prohibitionist policies while ignoring proven public health measures that we know reduce overdose death, like community naloxone distribution.”

 “As we feared, the Administration is using the overdose crisis as an excuse to ratchet up the war on drugs rather than an opportunity to save lives.” 

At this point, we can say that the news is not without skeptics. While many are still trying to remain hopeful that maybe because Kellyanne is so vocal and such a well-known surrogate for the president that perhaps she will be able to garner more attention to the issue.

While the fight for more resources continues, we should always encourage people to seek help. There are many safe and effective treatment resources already that have been helping people recover from drug and alcohol addiction for decades, like Palm Healthcare Company. If you or someone you love is struggling, please call toll-free now. We want to help. 

 CALL NOW 1-888-922-5398

Senator Investigating Vivitrol Drug Maker for Shady Marketing

Senator Investigating Vivitrol Drug Maker for Shady Marketing

The Big Pharma industry is still in the hot seat, and this week another lawmaker is adding a new name to the roster of drug makers to be investigated for shady marketing practices. Alkermes, the company behind the opioid treatment implant Vivitrol, is now being investigated for how they market their product.

Background on Vivitrol

Vivitrol is another name given to the generic drug Naltrexone. Originally approved by the U.S. Food and Drug Administration (FDA) for the treatment of alcohol dependence in 1994, Naltrexone eventually became approved for the treatment of opioid dependence. The medications primary use appears to be blocking the opiate receptors in the brain. It’s intended so that someone using heroin or other opiate-based drugs cannot experience the drugs high.

The Vivitrol shot is made by Boston-based biotech Alkermes. This medication stood out from other Naltrexone medications because Vivitrol is an injection given every 4 weeks with a monthly doctor visit. It is time released for longer lasting relief, instead of being a pill taken once a day.

Supposedly Vivitrol is intended to further help by reducing cravings for opioids. However, Naltrexone and Vivitrol have been refuted by many for having any notable effect on opioid cravings.

Enter Senator Harris

Kamala Harris is a Democratic California Senator who has announced she will be part of launching a new investigation into the sales and marketing practices of the makers of Vivitrol. According to the senator, Alkermes allegedly worked to increase sales of their opioid treatment medication through two questionable strategies:

  1. “Aggressively” marketing Vivitrol to officials in the criminal justice system

Senator Harris says that Alkermes pushes for judges and lawmakers to use their product. The company even provided free samples, which resulted in Vivitrol being actively implemented in 450 treatment programs across 39 states.

  1. Lobbying efforts by federal and state lawmakers

In her statement, Harris also alleges that the company has spent millions of dollars in direct appeals to government officials. Meanwhile, they were contributing to numerous congressional campaigns.

Due to the drug companies marketing, Vivitrol raked in well over $69 million dollars in the third quarter of 2017.

In her statement Senator Harris says,

“We are at the height of a crisis, and companies are taking advantage of pain in order to profit”

“We must hold these companies accountable for their deliberate actions that magnify the opioid epidemic and drive up the cost of drugs for Americans.”

The senator even quoted the chief of addiction medicine at Stanford University School of Medicine, Dr. Anna Lembke, who said,

“Alkermes has taken unethical drug promotion to new depths by enlisting judges, law enforcement personnel, and legislators to favor Vivitrol over proven treatments. Alkermes’ actions undermine public health.”

Which seems like some pretty strong words. In the midst of the opioid crisis, it might be fair to say we should use every resource we can get. However, the Big Pharma enterprises still need to be put in check when it comes to overlooking more effective treatments.

In fact, a 2011 review of studies suggested that Naltrexone was not significantly superior to placebo, and the authors believed there was no sufficient evidence to support Naltrexone therapy for opioid dependence.

Investigating Vivitrol

One reason Senator Harris seems to have Vivitrol in the crosshairs seems to be that the pharmaceutical company made a habit out of promoting Vivitrol as a more effective treatment than other maintenance drugs, such as Suboxone or Methadone, even though there is no substantive data to support this claim.

As part of the investigation, Harris contacted Richard Pops, the Alkermes Chairman, requesting the company provide data and communication. At the moment Alkermes is disputing the allegations. Senator Harris appears to be calling their bluff, as she was requested that Alkermes submit:

  • Marketing records

  • Financial records

  • Internal reports

Alkermes has also been asked to turn over any materials provided to participants or speakers for Alkermes since 2010. They’re being asked to disclose amounts paid to the company by various associations, including:

  • American Society of Addiction Medicine

  • National Institute on Drug Abuse (NIDA)

  • Partnership for Drug-Free Kids

Any studies presented to these groups are also to be turned in.

In their own statement, Alkermes states they are “focused on ensuring that patients, healthcare professionals, and criminal justice officials are educated on Vivitrol, and believes that patients should have access to all medications.”

There is no telling whether or not this investigation is going to turn into a witch hunt or if it will blow the lid off of even more bad behavior from Big Pharma. While other drug companies that can be connected to the opioid crisis are already facing lawsuits and others even criminal cases for racketeering and fraud, the Vivitrol producers might find themselves on the chopping block sooner rather than later.

There is already much disagreement about whether or not the Vivitrol treatment is really effective in the first place. Some say the medication helped save their life. Many others have horror stories of uncomfortable side-effects made worse by cravings. Either way, pharmaceutical companies still need to be held accountable for their marketing methods, especially when they seem a little suspect.

For now, this is all a request. Only Republican Senator Ron Johnson has the power to issue subpoenas on behalf of the Homeland and Governmental Affairs Committee.

When talking about the most effective treatment programs for addiction, we should also remember that maintenance drugs like Suboxone, Vivitrol and others are not exactly a solution. While they can be effective in keeping people alive and helping to overcome their sickness, the real healing does not come from magic pills or implants. The real transformation comes with developing the understand and the tools to take care of yourself. If you or someone you love is struggling, please call toll-free now.

 CALL NOW 1-888-922-5398

Pin It on Pinterest